Marwan Cheng Kuang Kwok

Publications

  1. 2021
  2. Published

    Cancer and COVID-19: on the quest for effective vaccines

    Marwan Cheng Kuang Kwok, & , Jan 2021, In: Blood Cancer Discovery. 2, 1, p. 13-18 6 p.

    Research output: Contribution to journalReview articlepeer-review

  3. 2020
  4. Published

    Genetics in the era of targeted CLL therapy

    Tatjana Stankovic & Marwan Cheng Kuang Kwok, 25 Jun 2020, In: Blood. 135, 26, p. 2333-2334 2 p.

    Research output: Contribution to journalComment/debatepeer-review

  5. Published
  6. 2019
  7. Published
  8. Published

    Outcomes following treatment discontinuation in CML: real-world experience from 3 regional UK centres

    Marwan Cheng Kuang Kwok, , , , , Manoj Raghavan & , Jun 2019, HemaSphere. Vol. 3. p. 884 (HemaSphere).

    Research output: Chapter in Book/Report/Conference proceedingConference contribution

  9. Published
  10. Published

    Targeting the Ataxia Telangiectasia and Rad3 Signaling Pathway to Overcome Chemoresistance in Cancer

    Marwan Cheng Kuang Kwok & Tatjana Stankovic, 2019, Targeting Cell Survival Pathways to Enhance Response to Chemotherapy. Johnson, D. E. (ed.). Elsevier, Vol. 3. p. 203-230

    Research output: Chapter in Book/Report/Conference proceedingChapter (peer-reviewed)peer-review

  11. 2018
  12. Published

    Targeting Replication Stress in Sporadic Tumours

    Marwan Cheng Kuang Kwok & Tatjana Stankovic, 4 Sep 2018, DNA Repair and Replication: Mechanisms and Cinical Significance. Grand, R. J. A. & Reynolds, J. J. (eds.). 1st ed. CRC Press, p. 329-340 22 p.

    Research output: Chapter in Book/Report/Conference proceedingChapter (peer-reviewed)peer-review

  13. Published
  14. 2017
  15. Published
  16. Published
  17. 2016
  18. Published

    Minimal residual disease is an independent predictor for 10-year survival in CLL

    Marwan Cheng Kuang Kwok, , , , , , , & , 15 Dec 2016, In: Blood. 128, 24, p. 2770-2773

    Research output: Contribution to journalArticlepeer-review

  19. Published
  20. 2015
  21. Published

    Kinetics of CLL Subclonal Architecture: Spontaneous Disease Progression or Treatment-Induced Selection?

    Ceri Oldreive, Nick Davies, Anna Skowronska, Marwan Cheng Kuang Kwok, , Paul Moss, Michael Griffiths, , Malcolm Taylor & Tatjana Stankovic, 3 Dec 2015, Blood. American Society of Hematology, Vol. 126. p. 167 (Blood).

    Research output: Chapter in Book/Report/Conference proceedingConference contribution

  22. Published
  23. 2014
  24. Published

    ATR Inhibition Exacerbates Replication Stress in TP53 or ATM Deficient CLL Cells and Enhances Sensitivity to Chemotherapy and Targeted Therapy

    Marwan Cheng Kuang Kwok, Nick Davies, Angelo Agathanggelou, , Eva Petermann, , , & Tatjana Stankovic, 6 Dec 2014, Blood. Vol. 124. p. 3340 (Blood).

    Research output: Chapter in Book/Report/Conference proceedingConference contribution

  25. Published

    CLL Progression Is Associated with Increased Clonal Diversity and Replication Stress

    Angelo Agathanggelou, Anna Skowronska, Nick Davies, Marwan Cheng Kuang Kwok, , , Malcolm Taylor & Tatjana Stankovic, 6 Dec 2014, Blood. Vol. 124. p. 1977 (Blood).

    Research output: Chapter in Book/Report/Conference proceedingConference contribution

  26. Published

    Independent prognostic significance of minimal residual disease status in chronic lymphocytic leukaemia

    Marwan Cheng Kuang Kwok, , , , , , , & , Feb 2014, Lancet. Vol. 383. p. S66 (The Lancet).

    Research output: Chapter in Book/Report/Conference proceedingConference contribution

  27. 2013
  28. Published

    Synthetic Lethality In CLL With DNA Damage Response Defect By Targeting ATR Pathway

    Tatjana Stankovic, Nick Davies, Marwan Cheng Kuang Kwok, , , Angelo Agathanggelou, & , 15 Nov 2013, Blood. Vol. 122. p. 120 (Blood).

    Research output: Chapter in Book/Report/Conference proceedingConference contribution

  29. 2010
  30. Published

    Achieving minimal residual disease (MRD) negativity in CLL is independently associated with improved progression-free and overall survival and is an appropriate end-point of therapy

    Marwan Cheng Kuang Kwok, , & , 2010, British Journal of Haematology. Vol. 149. p. 20 21 p. (British Journal of Haematology).

    Research output: Chapter in Book/Report/Conference proceedingConference contribution

Previous 1 2 Next